In CRC, alternative splicing can be regulated by trans-regulatory factors in form of mutations, dysregulated expressions or protein-modifications of RNA-binding proteins (RBPs) that occur in spliceosome components and splicing regulators [49, 50]. This evidence concerns the gene PTBP1 and colorectal carcinoma.